YEAR
- 2006.03.02 The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma. Yamauchi N, Watanabe A, Hishinuma M, Ohashi K, Midorikawa Y, Morishita Y, Niki T, Shibahara J, Mori M, Makuuchi M, Hippo Y, Kodama T, Iwanari H, Aburatani H, Fukayama M.Mod. Pathol. 2005 Dec;18(12):1591-8. doi: 10.1038/modpathol.3800436
- 2006.03.03 Fucoidan induces nitric oxide production via p38 mitogen-activated protein kinase and NF-kappaB-dependent signaling pathways through macrophage scavenger receptors. Nakamura T, Suzuki H, Wada Y, Kodama T, Doi T.Biochem. Biophys. Res. Commun. 2006 Apr 28;343(1):286-94. doi: 10.1016/j.bbrc.2006.02.146
- 2006.03.06 Macrophage scavenger receptor down-regulates mycobacterial cord factor-induced proinflammatory cytokine production by alveolar and hepatic macrophages. Ozeki Y, Tsutsui H, Kawada N, Suzuki H, Kataoka M, Kodama T, Yano I, Kaneda K, Kobayashi K.Microb. Pathog. 2006 Apr;40(4):171-6. doi: 10.1016/j.micpath.2005.12.006
- 2006.03.09 Three-dimensional structure of the gamma-secretase complex. Ogura T, Mio K, Hayashi I, Miyashita H, Fukuda R, Kopan R, Kodama T, Hamakubo T, Iwatsubo T, Tomita T, Sato C.Biochem. Biophys. Res. Commun. 2006 May 05;343(2):525-34. doi: 10.1016/j.bbrc.2006.02.158
- 2006.03.15 Human acyl-CoA:cholesterol acyltransferase 2 gene expression in intestinal Caco-2 cells and in hepatocellular carcinoma. Song BL, Wang CH, Yao XM, Yang L, Zhang WJ, Wang ZZ, Zhao XN, Yang JB, Qi W, Yang XY, Inoue K, Lin ZX, Zhang HZ, Kodama T, Chang CC, Liu YK, Chang TY, Li BL.Biochem. J. 2006 Mar 15;394(Pt 3):617-26. doi: 10.1042/BJ20051417
- 2006.03.28 WFS1-deficiency increases endoplasmic reticulum stress, impairs cell cycle progression and triggers the apoptotic pathway specifically in pancreatic beta-cells. Yamada T, Ishihara H, Tamura A, Takahashi R, Yamaguchi S, Takei D, Tokita A, Satake C, Tashiro F, Katagiri H, Aburatani H, Miyazaki J, Oka Y.Hum. Mol. Genet. 2006 May 15;15(10):1600-9. doi: 10.1093/hmg/ddl081
- 2006.03.29 Peroxisome proliferator-activated receptor delta (PPARdelta), a novel target site for drug discovery in metabolic syndrome. Takahashi S, Tanaka T, Kodama T, Sakai J.Pharmacol. Res. 2006 Jun;53(6):501-7. doi: 10.1016/j.phrs.2006.03.019
- 2006.04.01 Non-PKC DAG/phorbol-ester receptor(s) inhibit complement receptor-3 and nPKC inhibit scavenger receptor-AI/II-mediated myelin phagocytosis but cPKC, PI3k, and PLCgamma activate myelin phagocytosis by both. Cohen G, Makranz C, Spira M, Kodama T, Reichert F, Rotshenker S.Glia. 2006 Apr 01;53(5):538-50. doi: 10.1002/glia.20304
CLOSE